- ProductsInvestment SuiteExclusiveFeatures
- PlatformTrading PlatformsFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketMarket MoversStocksIndicesMutual FundsIPO
- LearnStockshaalaResourceInvesting GuideEvents
- Partner
- Support
Products
Platform
Research
Market
Learn
Compare ITI Pharma and Healthcare Fund vs Tata India Pharma & Healthcare Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 3.0 | 3.0 |
Min SIP Amount | ₹500 | ₹100 |
Expense Ratio | 2.35 | 2.11 |
NAV | ₹16.32 | ₹29.90 |
Fund Started | 18 Oct 2021 | 04 Dec 2015 |
Fund Size | ₹220.85 Cr | ₹1231.67 Cr |
Exit Load | Exit load of 0.50%, if redeemed within 3 months. | Exit load of 0.25% if redeemed within 30 days. |
Risk
Very High
Very High
Rating
3.0
3.0
Min SIP Amount
₹500
₹100
Expense Ratio
2.35
2.11
NAV
₹16.32
₹29.90
Fund Started
18 Oct 2021
04 Dec 2015
Fund Size
₹220.85 Cr
₹1231.67 Cr
Exit Load
Exit load of 0.50%, if redeemed within 3 months.
Exit load of 0.25% if redeemed within 30 days.
Returns
1 Year | 16.48% | 15.08% |
3 Year | 23.40% | 24.56% |
5 Year | - | 21.39% |
1 Year
16.48%
15.08%
3 Year
23.40%
24.56%
5 Year
-
21.39%
Holding Analysis
Equity | 99.70% | 90.83% |
Cash | 0.30% | 9.17% |
Equity
99.70%
90.83%
Cash
0.30%
9.17%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 15.18% |
Divi's Laboratories Ltd. | 9.12% |
Max Healthcare Institute Ltd. | 5.42% |
Lupin Ltd. | 5.40% |
Apollo Hospitals Enterprise Ltd. | 5.19% |
Cohance Lifesciences Ltd. | 4.84% |
Aurobindo Pharma Ltd. | 3.93% |
Torrent Pharmaceuticals Ltd. | 3.91% |
Aster DM Healthcare Ltd. | 3.15% |
Mankind Pharma Ltd. | 3.04% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.64% |
Apollo Hospitals Enterprise Ltd. | 6.22% |
Cipla Ltd. | 5.83% |
Aurobindo Pharma Ltd. | 5.73% |
Divi's Laboratories Ltd. | 5.63% |
Fortis Healthcare Ltd. | 4.90% |
Lupin Ltd. | 4.82% |
Aster DM Healthcare Ltd. | 4.35% |
Wockhardt Ltd. | 3.27% |
Dr. Reddy's Laboratories Ltd. | 3.16% |
Fund Manager
Name | Dhimant Shah | Meeta Shetty |
Start Date | 01 Dec 2022 | 09 Nov 2018 |
Name
Dhimant Shah
Meeta Shetty
Start Date
01 Dec 2022
09 Nov 2018
About Fund
Description | The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. | The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India. |
Launch Date | 18 Oct 2021 | 04 Dec 2015 |
Description
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Launch Date
18 Oct 2021
04 Dec 2015